WHO Scientific Advisory Group Releases In-Depth Report on the Origins of COVID-19 Amid Ongoing Calls for Transparency and Global Cooperation The World Health Organization (WHO) has taken another step forward in the complex and politically sensitive investigation into the origins…
WHO Launches Landmark Global Initiative to Advance Health Equity for Over 1.3 Billion People with Disabilities In a pivotal step toward realizing global health equity, the World Health Organization (WHO) officially launched the WHO Disability Health Equity Initiative on June…
UCB Announces Promising Phase 3 Results for Fenfluramine in CDKL5 Deficiency Disorder, Marking a Major Step Forward in Rare Epilepsy Treatment UCB, a global biopharmaceutical company committed to developing innovative therapies for neurological and immunological conditions, has announced positive top-line…
European Commission Grants Approval for Eylea™ 8 mg with Extended 6-Month Dosing Interval in Patients with nAMD and DME The European Commission (EC) has officially approved a label extension for Eylea™ 8 mg (aflibercept 8 mg, 114.3 mg/mL solution for…
Biogen Unveils New Data Underscoring the Long-Term Benefits and Advancements of Nusinersen in Spinal Muscular Atrophy Treatment Biogen, a global leader in neuroscience, has announced compelling new data that reinforces the clinical value and therapeutic potential of nusinersen, a pioneering…
Viatris Reports Positive Top-Line Results from Pivotal Phase 3 VEGA-3 Trial of MR-141 for Presbyopia, Underscoring Its Potential as a Non-Invasive Vision Correction Therapy Viatris, a global healthcare company committed to increasing access to high-quality medicines and health solutions worldwide,…
BeOne Medicines Showcases Bold Vision and Expansive Oncology Pipeline at 2025 R&D Day BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, delivered a comprehensive update to investors today during its highly anticipated Research and Development (R&D) Day. The event spotlighted…
CVS Health Launches Workforce Innovation and Talent Center in Chicago to Strengthen Community Employment and Training Opportunities In a significant step toward fostering economic opportunity and addressing workforce gaps, CVS Health has officially launched its newest Workforce Innovation and Talent…
FDA Approves Streamlined Monitoring Requirements and REMS Program Removal for Bristol Myers Squibb’s CAR T Cell Therapies Breyanzi and Abecma, Marking Milestone Toward Expanding Access to Cancer Treatment In a significant regulatory development, Bristol Myers Squibb announced that the U.S.…
Merck’s ENFLONSIA Receives ACIP Endorsement for RSV Prevention in Infants, Marking a Major Milestone in Pediatric Infectious Disease Prevention U.S. CDC panel backs long-acting monoclonal antibody to protect infants during their first RSV season; drug also included in federal Vaccines…
Global Energy Access Expands, But Urgent Financing Needed to Bridge Persistent Gaps and Achieve SDG 7 by 2030 A newly released edition of the Tracking SDG 7: The Energy Progress Report 2025 reveals that the world has made substantial strides…
Biogen Reports Promising Interim Phase 1 Results for Salanersen in Spinal Muscular Atrophy, Prepares for Registrational Trials Biogen has announced encouraging topline results from its Phase 1 clinical trial evaluating salanersen (BIIB115/ION306), an investigational antisense oligonucleotide (ASO) therapy for spinal…